Body Organ Biomedical Corp operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Body Organ Biomedical Corp with three other
pharmaceutical manufacturers in Asia:
Reber Genetics Co Ltd
sales of 37.51 million Taiwanese Dollars [US$1.19 million]
China Regenerative Medicine International Ltd
of Hong Kong
(2.82 million Hong Kong Dollars [US$363,167.64 ]
of which 75%
was Tissue Engineering), and
Syncore Biotechnology Co Ltd
(15.46 million Taiwanese Dollars [US$490,763.88 ]
During the year ended December of 2015, sales at
Body Organ Biomedical Corp were 24.56 million Taiwanese Dollars (US$779.57 thousand).
increase of 13.3%
versus 2014, when the company's sales were 21.67 million Taiwanese Dollars.
This was the fourth straight year of sales growth at Body Organ Biomedical Corp.